Original Article

Detection of Potentially Diagnostic Leishmania Antigens with Western Blot Analysis of Sera from Patients with Cutaneous and Visceral Leishmaniases

Abstract

Background: Visceral leishmaniasis (VL) and cutaneous leishmaniasis (CL) are important public health problems in Iran. We aimed to evaluate the diagnostic potential of Western blot (WB) compared with indirect immunofluorescence test (IFAT) to serodiagnosis of leishmaniasis.

Methods: This study was performed from 2010-2014 and participants were different parts of Iran. Serum samples were obtained from 43 patients with proven CL, 33 patients with proven VL, 39 patients with other parasitic diseases and 23 healthy individuals.

Results: WB sensitivity for CL and VL was 100% and 91%, compared to IFA 4.6% and 87.8%, respectively. Sera from patients with CL and VL recognized numerous antigens with molecular weights ranging from 14 to 68 kDa and 12 to 94 kDa, respectively. The most sensitive antigens were 14 and 16 kDa for CL recognized by 100% of the sera from patients with proven CL and 12, 14 and 16 kDa for VL, recognized by 63.6%, 100% and 63.6% of the sera from patients with proven VL respectively. WB analysis is more sensitive than IFAT for the diagnosis of leishmaniasis particularly in cases of cutaneous leishmaniasis. The 12, 14 and 16 kDa can be valuable diagnostic molecules for serodiagnosis of leishmaniasis because at least two immunogenic molecules were simultaneously detected by all patient sera, as well as produced antibodies against these antigens have no cross-reactivity with other control groups.

Conclusion: WB could be useful for screening and serodiagnosis of CL and VL in epidemiologic studies in endemic areas.

Ghotloo S, Hoseini MHM, Alimohammadian MH, et al. Immunomodulatory effects of chitin microparticles on Leishmania major infected BALB/c mice. Parasitol Int. 2015;64(2):219–21.

Hoseini MH, Moradi M, Alimohammadian MH, et al. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection. Parasitol Int. 2016;65(2):99–104.

Shiadeh MN, Niyyati M, Fallahi S, Rostami A. Human parasitic protozoan infection to infertility: a systematic review. Parasitol Res. 2016;115(2):469-77.

Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.

Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol. 2013;8(3):348-358.

Mitropoulos P, Konidas P, Durkin-Konidas M. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol. 2010;63(2):309–22.

Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873–82.

Mary C, Lamouroux D, Dunan S, Quilici M. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. Am J Trop Med Hyg. 1992;47(6):764–71.

Srivastava P, Dayama A, Mehrotra S, Sundar S. Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2011;105(1):1–6.

Elmahallawy EK, Martinez AS, Rodriguez-Granger J, et al. Diagnosis of leishmaniasis. J Infect Dev Ctries. 2014;8(8):961–72.

Oliveira E, Saliba SW, De Andrade CF, Rabello A. Direct agglutination test (DAT): improvement of biosafety for laboratory diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2011;105(7):414–6.

Cañavate C, Herrero M, Nieto J, et al. Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia. Am J Trop Med Hyg. 2011;84(1):102–6.

Goto H, Lindoso JAL. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010;8(4):419–33.

Fernández-Pérez FJ, Méndez S, de la Fuente C, et al. Value of Western blotting in the clinical follow-up of canine leishmaniasis. J Vet Diagn Invest. 1999;11(2):170–3.

Pomares C, Despierres L, del Giudice P, et al. Western blot analysis as an aid for the diagnosis of cutaneous leishmaniasis due to Leishmania major. Trans R Soc Trop Med Hyg. 2012;106(7):452–4.

Sakru N, Korkmaz M, Ozbel Y, et al. Investigation of asymptomatic visceral leishmaniasis cases using western blot in an endemic area in Turkey. New Microbiol. 2007;30(1):13-8.

Brito MEF, Mendonça MG, Gomes YM, Jardim ML, Abath FG. Identification of Potentially Diagnostic Leishmania braziliensis Antigens in Human Cutaneous Leishmaniasis by Immunoblot Analysis. Clin Diagn Lab Immunol. 2000;7(2):318–21.

Ravindran R, Anam K, Bairagi BC, et al. Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy. Infect Immun. 2004;72(2):863–70.

Riera C, Fisa R, Udina M, Gallego M, Portus M. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg. 2004;98(2):102–10.

Mikaeili F, Fakhar M, Sarkari B, Motazedian MH, Hatam G. Comparison of serological methods (ELISA, DAT and IFA) for diagnosis of visceral leishmaniasis utilizing an endemic strain. Iran J Immunol. 2007;4(2):116–21.

Gatti S, Gramegna M, Klersy C, et al. Diagnosis of visceral leishmaniasis: the sensitivities and specificities of traditional methods and a nested PCR assay. Ann Trop Med Parasitol. 2004;98(7):667–76.

Aisa MJ, Castillejo S, Gallego M, et al. Diagnostic potential of Western blot analysis of sera from dogs with leishmaniasis in endemic areas and significance of the pattern. Am J Trop Med Hyg. 1998;58(2):154–9.

Talmi-Frank D, Strauss-Ayali D, Jaffe C, Baneth G. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis. Clin Vaccine Immunol. 2006;13(2):271-6.

Zeyrek FY, Korkmaz M, Özbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL is highly endemic. Clin Vaccine Immunol. 2007;14(11):1409–15.

Gonçalves CCM, Reiche EMV, De Abreu Filho BA, et al. Evaluation of antigens from various Leishmania species in a Western blot for diagnosis of American tegumentary leishmaniasis. Am J Trop Med Hyg. 2002;66(1):91–102.

Valli LCP, Passos VMA, Dietze R, Callahan HL, Berman JD, Grogl M. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis. J Parasitol. 1999; 85(6):1076-83.

Files
IssueVol 12 No 2 (2017) QRcode
SectionOriginal Article(s)
Keywords
Visceral leishmaniasis Cutaneous leishmaniasis Diagnostic antigens Western blot IFAT
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
SEYYEDTABAEI SJ, ROSTAMI A, HAGHIGHI A, MOHEBALI M, KAZEMI B, FALLAHI S, SPOTIN A. Detection of Potentially Diagnostic Leishmania Antigens with Western Blot Analysis of Sera from Patients with Cutaneous and Visceral Leishmaniases. Iran J Parasitol. 2017;12(2):206-214.